Shanghai Pharmaceuticals Holding Co. (2607.HK) said it has agreed to set up a joint venture with a unit of private equity fund Primavera Capital Fund II L. P. for privatization of an Australia-listed healthcare company that is valued at 313 million Australian dollars ($237.5 million).
The Chinese pharmaceutical company said Thursday that it plans to set up a 60%-owned joint venture with Asia-based Primavera Capital Fund II L. P., which is founded by former Goldman Sachs executive Fred Hu, for a take-private deal of Vitaco Holdings Ltd. Primavera's unit PV Zeus Ltd. will own the remaining 40% in the joint venture company, it said.
Shanghai Pharmaceuticals said the offer price for Vitaco, which sells and makes a series of nutrition and healthcare products, is A$2.25 per share, representing 27.8% of Vitaco's last closing price on Wednesday. Vitaco, which was listed on the Australian Securities Exchange in September 2015, reported a net profit of A$9.6 million for the year ended March, 2015.
The deal would allow Shanghai Pharma to enter into healthcare products sector and benefit from its future growth, it said.
- Forums
- ASX - By Stock
- VIT
- Shangai
Shangai
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.7¢ |
Change
-0.002(2.25%) |
Mkt cap ! $50.10M |
Open | High | Low | Value | Volume |
8.5¢ | 8.7¢ | 8.3¢ | $18.38K | 215.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 202500 | 8.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.7¢ | 6129 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 202500 | 0.081 |
2 | 97500 | 0.080 |
1 | 100000 | 0.078 |
1 | 6003 | 0.077 |
1 | 6579 | 0.076 |
Price($) | Vol. | No. |
---|---|---|
0.087 | 6129 | 1 |
0.089 | 428497 | 1 |
0.090 | 11144 | 1 |
0.094 | 1300 | 1 |
0.095 | 6700 | 1 |
Last trade - 15.52pm 11/10/2024 (20 minute delay) ? |
Featured News
VIT (ASX) Chart |